Skip to content
Certified ManufacturersFor manufacturers

Rasi Laboratories, Inc.

Cranbury, NJ, United States

Due-diligence report

Find an accredited testing lab and confirm its scope covers your product and methods.

Rasi Laboratories, Inc. is a dietary supplement manufacturer in Cranbury, NJ, United States, certified to NSF/ANSI 455-2 GMP, with 1 manufacturing facility on NSF’s public NSF/ANSI 455 listing as of November 19, 2026. Listed dosage forms: capsules, powders and tablets.

Facilities listed
1
Last checked

Dosage forms

As listed in the product categories of this company’s NSF/ANSI 455-2 certified facilities.

Certified facilities

Manufacturing (1)

  • 320 Half Acre Road, Cranbury, NJ 08512, United States

    • Coating
    • Dry Formulation
    • Encapsulation
    • Mixing
    • Packaging/Labeling Operation
    • Packaging/Labeling Operation - Bulk Packaging
    • Packaging/Labeling Operation - Primary Packaging
    • Packaging/Labeling Operation - Secondary Packaging
    • Quality Unit Operations
    • Tablet Compression
    • Warehousing

How Rasi Laboratories, Inc. compares

Among the 769 manufacturers we list, as of our last check.

FDA recall records

No food or dietary supplement recall found under the name Rasi Laboratories, Inc. in FDA’s enforcement reports, as of .

We match FDA records by company name only. A recall listed under a different name won’t appear here, and a different company with the same name could. FDA’s food enforcement records start in June 2012. How we check

FDA inspections

FDA lists 6 food or dietary supplement inspections at facilities matching Rasi Laboratories, Inc., from 2010 to 2023, as of . 2 found no objectionable conditions, 3 found conditions the firm was left to correct, and 1 led FDA to recommend official action.

  • No action indicated · No objectionable conditions found

    Inspected

    Cranbury, New Jersey

    FEI 2245465

  • No action indicated · No objectionable conditions found

    Inspected

    Cranbury, New Jersey

    FEI 2245465

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Cranbury, New Jersey

    1 citation posted:

    • Procedures - equipment - cleaning, sanitizing (21 CFR 111.25(c))
    Full citation text
    • Procedures - equipment - cleaning, sanitizing (21 CFR 111.25(c))

      You did not establish and follow written procedures for maintaining, cleaning, and sanitizing, equipment, utensils, and any other contact surfaces that are used to manufacture, package, label, or hold components or dietary supplements.

    FEI 2245465

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Cranbury, New Jersey

    3 citations posted:

    • Specifications - component identity (21 CFR 111.70(b)(1))
    • Specifications met - verify; finished batch (21 CFR 111.75(c))
    • Quality control operations - returned dietary supplement (21 CFR 111.130)
    Full citation text
    • Specifications - component identity (21 CFR 111.70(b)(1))

      You did not establish an identity specification for each component.

    • Specifications met - verify; finished batch (21 CFR 111.75(c))

      You did not verify that your finished batch of dietary supplement meets product specifications for identity, purity, strength, and composition.

    • Quality control operations - returned dietary supplement (21 CFR 111.130)

      You do not have quality control operations for returned dietary supplements.

    FEI 2245465

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Cranbury, New Jersey

    1 citation posted:

    • Specifications met - identity, purity, strength, composition (21 CFR 111.73)
    Full citation text
    • Specifications met - identity, purity, strength, composition (21 CFR 111.73)

      You did not determine whether you met established product specifications for purity, strength, and composition of the finished batch of the dietary supplement.

    FEI 2245465

Show all 6 inspections
  • No action indicated · No objectionable conditions found

    Inspected

    Cranbury, New Jersey

    FEI 2245465

  • No action indicated · No objectionable conditions found

    Inspected

    Cranbury, New Jersey

    FEI 2245465

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Cranbury, New Jersey

    1 citation posted:

    • Procedures - equipment - cleaning, sanitizing (21 CFR 111.25(c))
    Full citation text
    • Procedures - equipment - cleaning, sanitizing (21 CFR 111.25(c))

      You did not establish and follow written procedures for maintaining, cleaning, and sanitizing, equipment, utensils, and any other contact surfaces that are used to manufacture, package, label, or hold components or dietary supplements.

    FEI 2245465

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Cranbury, New Jersey

    3 citations posted:

    • Specifications - component identity (21 CFR 111.70(b)(1))
    • Specifications met - verify; finished batch (21 CFR 111.75(c))
    • Quality control operations - returned dietary supplement (21 CFR 111.130)
    Full citation text
    • Specifications - component identity (21 CFR 111.70(b)(1))

      You did not establish an identity specification for each component.

    • Specifications met - verify; finished batch (21 CFR 111.75(c))

      You did not verify that your finished batch of dietary supplement meets product specifications for identity, purity, strength, and composition.

    • Quality control operations - returned dietary supplement (21 CFR 111.130)

      You do not have quality control operations for returned dietary supplements.

    FEI 2245465

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Cranbury, New Jersey

    1 citation posted:

    • Specifications met - identity, purity, strength, composition (21 CFR 111.73)
    Full citation text
    • Specifications met - identity, purity, strength, composition (21 CFR 111.73)

      You did not determine whether you met established product specifications for purity, strength, and composition of the finished batch of the dietary supplement.

    FEI 2245465

  • Official action indicated · Regulatory or administrative action recommended

    Inspected

    Cranbury, New Jersey

    10 citations posted:

    • Procedures - equipment - cleaning, sanitizing (21 CFR 111.25(c))
    • Specifications met - identity, purity, strength, composition (21 CFR 111.73)
    • Quality control - ensure quality; package, labeled, master record (21 CFR 111.105)
    • Sampling plans; establish, follow (21 CFR 111.315(b))
    See all 10 citations
    • Procedures - equipment - cleaning, sanitizing (21 CFR 111.25(c))

      You did not establish and follow written procedures for maintaining, cleaning, and sanitizing, equipment, utensils, and any other contact surfaces that are used to manufacture, package, label, or hold components or dietary supplements.

    • Specifications met - identity, purity, strength, composition (21 CFR 111.73)

      You did not determine whether you met established product specifications for identity, purity, strength, and composition of the finished batch of the dietary supplement.

    • Quality control - ensure quality; package, labeled, master record (21 CFR 111.105)

      Your quality control personnel did not ensure that your manufacturing operations ensure the quality of the dietary supplement.

    • Sampling plans; establish, follow (21 CFR 111.315(b))

      You did not follow sampling plans for obtaining representative samples.

    • Hold - temperature, humidity, light (21 CFR 111.455(a))

      You did not hold components and dietary supplements under appropriate conditions of temperature, humidity, or light so that their identity, purity, strength, and composition are not affected.

    • Training--operations, GMPs, written procedures (21 CFR 211.25(a))

      Employees are not given training in the particular operations they perform as part of their function and written procedures required by current good manufacturing practice regulations.

    • Identity Testing of Each Component (21 CFR 211.84(d)(1))

      The identity of each component of a drug product is not verified by conducting at least one test to verify the identity, using specific identity tests if they exist.

    • Investigations of discrepancies, failures (21 CFR 211.192)

      There is a failure to thoroughly review the failure of a batch or any of its components to meet any of its specifications whether or not the batch has been already distributed.

    • Complete test data included in records (21 CFR 211.194(a))

      Laboratory records do not include complete data derived from all tests, examinations and assay necessary to assure compliance with established specifications and standards.

    • Procedures to be written and followed (21 CFR 211.198(a))

      Procedures describing the handling of all written and oral complaints regarding a drug product are not followed.

    FEI 2245465

We match FDA inspections to companies by facility ZIP code (or city outside the US) and company name, so an inspection filed under a different name won’t appear here. FDA publishes final classifications only, and holds some back while enforcement is pending. Posted citations may differ from FDA’s final findings. FDA Data Dashboard · How we check

What we checked, and what we didn’t

Confirmed from NSF’s public listing

Last checked

  • NSF/ANSI 455-2 GMP certification
  • 1 facility address
  • Dosage forms in the certified scope
  • Operations listed for each facility

Not verified by us

  • Minimum order quantity (MOQ): the smallest order they accept
  • Lead times and current capacity
  • Prices
  • Other certifications, like organic, kosher, halal or NSF Certified for Sport
  • Whether they’re taking new clients
  • Conditions inside the facility. We don’t visit or audit facilities.

Ask about these in your quote request. How we verify

Other capsule manufacturers in the United States

  1. NSF lists 5 capsule facilities, including one in Tempe, AZ

    Tempe, AZ, United States21stcenturyvitamins.com

    • Capsules
    • Gummies
    • Softgels
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Tablet compression
    • Encapsulation
    NSF/ANSI 455-2checked Nov 19, 2026
  2. NSF lists a capsule facility in Centennial, CO

    Centennial, CO, United States5280smc.com

    • Capsules
    Operations:
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026
  3. NSF lists a capsule facility in Garden Grove, CA

    Garden Grove, CA, United Statespackaging.com

    • Capsules
    • Gummies
    • Powders
    • Softgels
    • Tablets
    NSF/ANSI 455-2checked Nov 19, 2026
  4. NSF lists a capsule facility in Ada, MI

    Ada, MI, United Statesamway.com

    • Capsules
    • Powders
    • Softgels
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Tablet compression
    • Encapsulation
    • +1 more
    NSF/ANSI 455-2checked Nov 19, 2026
  5. NSF lists 2 capsule facilities, including one in Chandler, AZ

    Gilbert, AZ, United Statesadeptlifesciences.com

    • Capsules
    • Liquids
    • Powders
    • Tablets
    Operations:
    • Liquid formulation
    • Tablet compression
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026
  6. NSF lists a capsule facility in Congers, NY

    Congers, NY, United Statesadhhealth.com

    • Capsules
    • Oils
    • Powders
    • Tablets
    Operations:
    • Coating
    • Tablet compression
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026